AlphaYouKG
Insider selling
Kathryn Guarini sold $340K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Kathryn Guarini, Dir of Regeneron Pharmaceuticals, Inc. (REGN), sold 400 shares of REGN stock worth $340K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 2, 2026, 1 day before it was made public.
REGN has moved -5.6% since the trade date, from $852.03 to $803.90 (Sep 22, 2026 close).
- Traded
- Sep 2, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 1 day
- Price since
- -5.6%
- Role
- Dir
- Source
- SEC Form 4
More REGN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.